BATRK ATL Braves stock climbs 279 percent despite Q4 2025 EPS miss that fell short of analyst estimates CME Group Inc CME Valuation Assessment Amid Recent NearTerm Share Price Pullback SSSS SuRo Capital posts far wider Q4 2025 loss than consensus estimates shares dip 069 percent today